Brown Advisory Inc. Increases Position in agilon health, inc. (NYSE:AGL)

Brown Advisory Inc. raised its position in agilon health, inc. (NYSE:AGLGet Rating) by 3.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,500,028 shares of the company’s stock after purchasing an additional 107,072 shares during the quarter. Brown Advisory Inc.’s holdings in agilon health were worth $88,757,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. O Dell Group LLC acquired a new position in shares of agilon health in the 4th quarter worth approximately $27,000. Advisor Group Holdings Inc. lifted its holdings in agilon health by 899.4% during the 4th quarter. Advisor Group Holdings Inc. now owns 1,669 shares of the company’s stock worth $47,000 after buying an additional 1,502 shares in the last quarter. Gleason Group Inc. acquired a new stake in agilon health during the 1st quarter worth approximately $55,000. Centiva Capital LP acquired a new stake in agilon health during the 4th quarter worth approximately $243,000. Finally, PEAK6 Investments LLC lifted its holdings in agilon health by 189.8% during the 4th quarter. PEAK6 Investments LLC now owns 9,275 shares of the company’s stock worth $250,000 after buying an additional 6,075 shares in the last quarter. 96.24% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AGL has been the topic of a number of research reports. Truist Financial increased their target price on shares of agilon health from $30.00 to $33.00 and gave the stock a “buy” rating in a report on Thursday, July 14th. TheStreet upgraded shares of agilon health from a “d+” rating to a “c-” rating in a report on Friday, July 15th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of agilon health from $30.00 to $26.00 in a report on Tuesday, May 10th. Guggenheim dropped their price objective on shares of agilon health from $32.00 to $30.00 in a research report on Tuesday, May 10th. Finally, BTIG Research began coverage on shares of agilon health in a research report on Friday, June 24th. They issued a “neutral” rating on the stock. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, agilon health currently has a consensus rating of “Moderate Buy” and an average target price of $33.50.

agilon health Trading Up 0.3 %

NYSE AGL opened at $25.59 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.67 and a quick ratio of 2.67. The firm’s fifty day moving average price is $22.87 and its 200 day moving average price is $21.17. The company has a market capitalization of $10.41 billion, a price-to-earnings ratio of -91.39 and a beta of 1.76. agilon health, inc. has a 12 month low of $14.36 and a 12 month high of $38.47.

agilon health (NYSE:AGLGet Rating) last posted its earnings results on Thursday, August 4th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). agilon health had a negative net margin of 4.99% and a negative return on equity of 9.79%. During the same quarter in the previous year, the company earned ($0.06) earnings per share. On average, sell-side analysts expect that agilon health, inc. will post -0.11 earnings per share for the current fiscal year.

Insider Activity at agilon health

In related news, insider Benjamin Shaker sold 50,000 shares of the stock in a transaction on Thursday, July 21st. The shares were sold at an average price of $27.72, for a total value of $1,386,000.00. Following the transaction, the insider now directly owns 27,132 shares of the company’s stock, valued at approximately $752,099.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, insider Benjamin Shaker sold 50,000 shares of the stock in a transaction on Thursday, July 21st. The shares were sold at an average price of $27.72, for a total value of $1,386,000.00. Following the transaction, the insider now directly owns 27,132 shares of the company’s stock, valued at approximately $752,099.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Benjamin Kornitzer sold 8,094 shares of the stock in a transaction on Monday, July 18th. The stock was sold at an average price of $26.57, for a total transaction of $215,057.58. Following the sale, the insider now owns 10,853 shares of the company’s stock, valued at approximately $288,364.21. The disclosure for this sale can be found here. Insiders have sold 711,053 shares of company stock valued at $16,617,223 in the last ninety days. Insiders own 3.30% of the company’s stock.

agilon health Profile

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.

Read More

Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGLGet Rating).

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.